AVITA Medical, Inc.

NasdaqCM:RCEL Stock Report

Market Cap: US$349.9m

AVITA Medical Balance Sheet Health

Financial Health criteria checks 3/6

AVITA Medical has a total shareholder equity of $12.2M and total debt of $42.5M, which brings its debt-to-equity ratio to 348%. Its total assets and total liabilities are $81.1M and $68.8M respectively.

Key information

348.0%

Debt to equity ratio

US$42.55m

Debt

Interest coverage ration/a
CashUS$44.41m
EquityUS$12.23m
Total liabilitiesUS$68.82m
Total assetsUS$81.05m

Recent financial health updates

Recent updates

AVITA Medical, Inc.'s (NASDAQ:RCEL) Share Price Boosted 26% But Its Business Prospects Need A Lift Too

Oct 04
AVITA Medical, Inc.'s (NASDAQ:RCEL) Share Price Boosted 26% But Its Business Prospects Need A Lift Too

AVITA Medical, Inc. (NASDAQ:RCEL) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Aug 11
AVITA Medical, Inc. (NASDAQ:RCEL) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

AVITA Medical, Inc.'s (NASDAQ:RCEL) Share Price Boosted 26% But Its Business Prospects Need A Lift Too

Jul 18
AVITA Medical, Inc.'s (NASDAQ:RCEL) Share Price Boosted 26% But Its Business Prospects Need A Lift Too

Is AVITA Medical (NASDAQ:RCEL) A Risky Investment?

Jun 18
Is AVITA Medical (NASDAQ:RCEL) A Risky Investment?

Little Excitement Around AVITA Medical, Inc.'s (NASDAQ:RCEL) Revenues As Shares Take 39% Pounding

Apr 12
Little Excitement Around AVITA Medical, Inc.'s (NASDAQ:RCEL) Revenues As Shares Take 39% Pounding

AVITA Medical, Inc.'s (NASDAQ:RCEL) Price Is Right But Growth Is Lacking After Shares Rocket 39%

Feb 02
AVITA Medical, Inc.'s (NASDAQ:RCEL) Price Is Right But Growth Is Lacking After Shares Rocket 39%

The Market Doesn't Like What It Sees From AVITA Medical, Inc.'s (NASDAQ:RCEL) Revenues Yet As Shares Tumble 32%

Oct 20
The Market Doesn't Like What It Sees From AVITA Medical, Inc.'s (NASDAQ:RCEL) Revenues Yet As Shares Tumble 32%

Avita Medical appoints James Corbett as CEO

Sep 29

AVITA Medical says trial evaluating its RECELL system to treat vitiligo met main goal

Sep 12

Avita's burn therapy Recell gets insurance coverage in Japan following approval

Sep 01

AVITA Medical GAAP EPS of -$0.25 beats by $0.15, revenue of $8.34M beats by $1.18M

Aug 11

AVITA Medical Is Interesting, But Not Just Yet

Dec 21

AVITA Medical reports preliminary Q2 revenue in-line with consensus

Jan 12

AVITA: COVID-19's Impact

Nov 17

Financial Position Analysis

Short Term Liabilities: RCEL's short term assets ($63.9M) exceed its short term liabilities ($17.1M).

Long Term Liabilities: RCEL's short term assets ($63.9M) exceed its long term liabilities ($51.7M).


Debt to Equity History and Analysis

Debt Level: RCEL has more cash than its total debt.

Reducing Debt: RCEL's debt to equity ratio has increased from 0% to 348% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: RCEL has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if RCEL has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Discover healthy companies